Systemically, administering Ccl2 and Il13 is sufficient to cause metastasis of MYC-HCC and, conversely blocking these specific cytokines profoundly inhibits metastasis in MYC/Twist1 HCC. Here, CCL2 is linked to hepatocellular carcinoma.